Warning: Javascript must be enabled within your browser's settings for this site to function properly.

Your browser appears to be out of date, and is not supported by this site. For the best experience, we recommend that you upgrade to a more modern browser. You can find a list of modern browsers from www.browsehappy.com.

We use technical and analytics cookies data to ensure that we give you the best experience on our website. For more information visit our Privacy Page.

BWXT $   $  
As of . Minimum 20 minute delay.

News

BWXT Named First Member of GE Vernova Nuclear’s Small Modular Reactor Supplier Group

29 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. has been selected as the first qualified supply chain company to join the GE Vernova nuclear business’ supplier group that will advance the global deployment of the BWRX-300 small modular reactor (SMR).


BWXT Announces Expansion of Cambridge Manufacturing Plant to Support Global Nuclear Power Market

19 April 2024

BWX Technologies, Inc. (NYSE: BWXT) announced an investment to expand its Cambridge manufacturing plant.


BWXT Canada Joins Canadians for CANDU® Campaign

11 April 2024

BWXT Canada Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT), has joined the Canadians for CANDU Campaign.


BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology

16 November 2023

(OTTAWA, Ontario – November 16, 2023) – BWXT Medical Ltd. and Fusion Pharmaceuticals Inc. (Nasdaq: FUSN) today announced that the companies have entered into an agreement for the supply of generators to produce actinium-225, a medical isotope used to treat cancer in clinical trials.



Scott Gray Appointed Executive Vice President, Project & Field Services for Commercial Operations

30 March 2022

(CAMBRIDGE, ON. – March 30, 2022) – BWX Technologies, Inc. (NYSE: BWXT) today announced that it has named Scott Gray to the position of Executive Vice President of Projects & Field Services for BWXT’s Commercial Operations segment (BWXT) effective April 1, 2022.


BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225

16 September 2021

(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.


BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power

19 August 2021

BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.


BWXT Medical Enters into a New Long-Term Agreement with Boston Scientific

10 May 2021

(Ottawa, Ontario – May 10, 2021) – BWXT Medical Ltd. (BWXT Medical) announced today that it has entered into a new long-term, mutually exclusive agreement to manufacture TheraSphere™ Y-90 Glass Microspheres for Boston Scientific, a leading global medical device company.


BWXT Renames Laker Energy Products to BWXT Precision Manufacturing

16 March 2021

(OAKVILLE, ON – March 16, 2021) – BWXT Canada Ltd. announced today that it has renamed its subsidiary Laker Energy Products Ltd. to BWXT Precision Manufacturing Inc.

Press Contacts:

BWX Technologies, Inc.

Jud Simmons 
+1 434.522.3800
hjsimmons@bwxt.com

BWXT Canada Ltd.
BWXT Nuclear Energy Canada Inc.
BWXT Medical Ltd.

Monifa Miller
+1 519.242.8071
mamiller@bwxt.com 

Nuclear Fuel Services, Inc.

Laura Bailey 
+1 423.743.9141
lebailey@nuclearfuelservices.com 

Archive

Tags